Severe alcohol withdrawal syndrome: Evolution of care and impact of adjunctive therapy on course and complications of 171 intensive care unit patients

References

• Kraemer KL, Mayo-Smith MF, Calkins DR. Independent clinical correlates of severe alcohol withdrawal. Subst Abus 2003; 24(4):197–209.
   PubMedGoogle Scholar
• Goodson CM, Clark BJ, Douglas IS. Predictors of severe alcohol withdrawal syndrome: a systematic review and meta-analysis. Alcohol Clin Exp Res 2014; 38(10):2664–77.
   PubMed Web of Science ®Google Scholar
• Maldonado JR, Sher Y, Ashouri JF, et al. The “Prediction of Alcohol Withdrawal Severity Scale (PAWSS):” systematic literature review and pilot study of a new scale for the prediction of complicated alcohol withdrawal syndrome. Alcohol 2014; 48(4):375–90.
   PubMed Web of Science ®Google Scholar
• Monte R, Rabunal R, Casariego E, Lopez-Agreda H, Mateos A, Pertega S. Analysis of the factors determining survival of alcoholic withdrawal syndrome patients in a general hospital. Alcohol Alcohol 2010; 45(2):151–8.
   PubMed Web of Science ®Google Scholar
• Ferguson JA, Suelzer CJ, Eckert GJ; Zhou XH, Dittus RS. Risk factors for delirium tremens development. J Gen Intern Med 1996; 11(7):410–4.
   PubMed Web of Science ®Google Scholar
• Sarff M, Gold JA. Alcohol withdrawal syndromes in the intensive care unit. Crit Care Med 2010; 38(9 Suppl):s484–501.
   Google Scholar
• Carlson RW, Kumar NN, Wong-Mckinstry E, et al. Alcohol withdrawal syndrome. Crit Care Clin 2012; 28(4):549–85.
   PubMed Web of Science ®Google Scholar
• Srivatasv N, McKinstry EW, Ayyagari S, Drachman D, Carlson RW. Review of respiratory complications in alcohol withdrawal syndrome (AWS) at a public hospital. Crit Care Med 2008; 36(suppl 12):A138.
   Web of Science ®Google Scholar
• Rovasalo A, Tohmo H, Aantaa R, Kettunen E, Palojoki R. Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report. Gen Hosp Psychiatry 2006; 28(4):362–3.
   PubMed Web of Science ®Google Scholar
• Darrouj J, Puri N, Prince E, Lomonaco A, Spevetz A, Gerber DR. Dexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal. Ann Pharmacother 2008; 42(11):1703–5.
   PubMed Web of Science ®Google Scholar
• Ait-Daoud N, Malcolm RJ, Jr. Johnson BA. An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants. Addict Behav 2006; 31(9):1628–49.
   PubMed Web of Science ®Google Scholar
• Tolonen J, Rossinen J, Alho H, Harjola VP. Dexmedetomidine in addition to benzodiazepine-based sedation in patients with alcohol withdrawal delirium. Eur J Emerg Med 2013; 20(6):425–7.
   PubMed Web of Science ®Google Scholar
• Coomes TR, Smith SW. Successful use of propofol in refractory delirium tremens. Ann of Emerg Med 1997; 30(6); 825–8.
   PubMed Web of Science ®Google Scholar
• Rayner SG, Weinert CR, Peng H, Jepsen S, Broccard AF. Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU. Ann Inten Care 2012; 2(1):12.
   PubMed Web of Science ®Google Scholar
• Mueller SW, Preslaski CR, Kiser TH, et al. A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal. Crit Care Med 2014; 42(5):1131–9.
   PubMed Web of Science ®Google Scholar
• McCowan C, Marik P. Refractory delirium tremens treated with propofol: a case series. Crit Care Med 2000; 28(6):1781–4.
   PubMed Web of Science ®Google Scholar
• Lorentzen K, Lauritsen AO, Bendtsen AO. Use of propofol infusion in alcohol withdrawal-induced refractory delirium tremens. Dan Med J 2014; 61(5):A4807.
   PubMed Web of Science ®Google Scholar
• Frazee EN, Personett HA, Leung JG, Nelson S, Dierkhising RA, Bauer PR. Infuence of dexmedetomidine therapy on the management of severe alcohol withdrawal syndrome in critically ill patients. J Crit Care 2014; 29(2):298–302.
   PubMed Web of Science ®Google Scholar
• Crispo AL, Daley MJ, Pepin JL, Harford PH, Brown CV. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: Dexmedetomidine versus benzodiazepines. Pharmacotherapy 2014; 34(9):910–7.
   PubMed Web of Science ®Google Scholar
• VanderWeide LA, Foster CJ, MacLaren R, Kiser TH, Fish DN, Mueller SW. Evaluation of early Dexmedeomidine addition to the standard of care for severe alcohol withdrawal in the ICU: a retrospective controlled cohort study. J Intensive Care Med 2016; 31(3):198–204.
   PubMed Web of Science ®Google Scholar
• DeMuro JP, Botros DG, Wirkowski E, Hanna AF. Use of dexmedetomidine for the treatment of alcohol withdrawal syndrome in crtically ill patients: a retrospective case series. J Anesth 2012; 26(4):601–5.
   PubMed Web of Science ®Google Scholar
• Muzyk AJ, Kerns S, Brudney S, Gagliardi JP. Dexmedetomidine for the treatment of alcohol withdrawal syndrome: rationale and current state of research. CNS Drugs 2013; 27(11):913–20.
   PubMed Web of Science ®Google Scholar
• Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar). Br J Addict 1989; 84(11):1353–7.
   PubMedGoogle Scholar
• Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J 1974; 2(5920):656–9.
   PubMed Web of Science ®Google Scholar
• Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002; 166(10):1338–44.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Washington DC: American Psychiatric Association, 2000. Substance-Induced delirium tremens (alcohol 291.0).
   Google Scholar
• Maldonado JR, Nguyen LH, Schader EM, Brooks JO, 3rd. Benzodiazepine loading versus symptom-triggered treatment of alcohol withdrawal: a prospective, randomized clinical trial. Gen Hosp Psych 2012; 34(6):611–7.
   PubMed Web of Science ®Google Scholar
• Daeppen JB, Gache P, Landry U, et al. Symptom-triggered vs. fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Arch Intern Med 2002; 162(10):1117–21.
   PubMed Web of Science ®Google Scholar
• Shu JE, Lin A, Chang G. Alcohol withdrawal treatment in the medically hospitalized patient: a pilot study assessing predictors for medical or psychiatric complications. Psychosomatics 2015; 56(5):547–55.
   PubMed Web of Science ®Google Scholar
• Awissi DK, Lebrun G, Coursin DB, Riker RR, Skrobik Y. Alcohol withdrawal and delirium tremens in the critically ill: a systematic review and commentary. Intensive Care Med 2013; 39(1):16–30.
   PubMed Web of Science ®Google Scholar
• Mayo-Smith MF. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA 1997; 278(2):144–51.
   PubMed Web of Science ®Google Scholar
• Perry EC. Inpatient management of acute alcohol withdrawal syndrome. CNS Drugs 2014; 28(5):401–10.
   PubMed Web of Science ®Google Scholar
• Manasco A, Chang S, Larriviere J, Hamm LL, Glass M. Alcohol withdrawal. South Med J 2012; 105(11):607–12.
   PubMed Web of Science ®Google Scholar
• Schuckit MA. Recognition and management of withdrawal delirium (delirium tremens). N Engl J Med 2014; 371(22):2109–13.
   PubMed Web of Science ®Google Scholar
• Albertson TE, Chenoweth J, Ford J, Owen K, Sutter ME. Is it prime time for alpha2-adrenoceptor agonists in the treatment of withdrawal syndromes? J Med Toxicol 2014; (4):369–81.
   PubMedGoogle Scholar
• Wong A, Smithburger PL, Kane-Gill SL. Review of adjunctive dexmedetomidine in the management of severe alcohol withdrawal syndrome. Am J Drug Alcohol Abuse 2015; 41(5):382–91.
   Web of Science ®Google Scholar